삼성서울병원

Ko En

Breast Surgery Chae, Byung Joo M.D , MD. PhD. FACS

Expertise
Breast Cancer, liquid biopsy, survivorship, precision medicine, oncoplastic surgery
Treament Schedule 05 月
DATE
THU
01
FRI
02
SAT
03
SUN
04
MON
05
TUE
06
WEB
07
THU
08
FRI
09
SAT
10
SUN
11
MON
12
TUE
13
WEB
14
THU
15
FRI
16
SAT
17
SUN
18
MON
19
TUE
20
WEB
21
THU
22
FRI
23
SAT
24
SUN
25
MON
26
TUE
27
WEB
28
THU
29
FRI
30
SAT
31
AM
PM
Treament Schedule 06 月
DATE
SUN
01
MON
02
TUE
03
WEB
04
THU
05
FRI
06
SAT
07
SUN
08
MON
09
TUE
10
WEB
11
THU
12
FRI
13
SAT
14
SUN
15
MON
16
TUE
17
WEB
18
THU
19
FRI
20
SAT
21
SUN
22
MON
23
TUE
24
WEB
25
THU
26
FRI
27
SAT
28
SUN
29
MON
30
AM
PM

Medical Education

2004~2010 Ph.D. Graduate Schools, The Catholic University of Korea, Seoul, Korea
2001~2004 M.S Graduate Schools, The Catholic University of Korea, Seoul, Korea
1994~2000 M.D College of Medicine, The Catholic University of Korea, Seoul, Korea

Post-Graduate Training

Fellowship   2008~2011 Breast Surgical Oncology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
Residency   2001~2005 Surgery, Catholic Medical Center, Seoul, Korea
Internship   2000~2001 Seoul Red Cross Hospital, Seoul, Korea

Professional Appointments

2022.2~present Professor Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine
2019.03~2022.2 Clinical Associate Professor Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine
2017.03~2019.01 Associate Professor Division of Breast Surgery, Department of Surgery,Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
2014.03~2015.02 Visiting Assistant Professor Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, University of Texas, Texas, U.S.A
2013.03~2017.02 Assistant Professor Department of Surgery, Division of Breast Surgery, Department of Surgery,Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
2011.03~2013.02 Clinical Assistant Professor Division of Breast Surgery, Department of Surgery, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea

Professional Memberships

2016~Present Member Fellow of American College of Surgeon
2008~Present Member Korean Society of Clinical Oncology
2008~Present Member Korean Association of Thyroid and Endocrine Surgeons
2008~Present Member Korean Breast Cancer Society
2005~Present Member Korean Surgical Society
2000~Present Member The Korean Medical Association

Selected Publications

  • CANCER-AM CANCER SOC 2025 10.1002/cncr.35699 Reply to De-escalation of axillary surgery in patients with sentinel lymph node micrometastases after neoadjuvant systemic therapy Shin, DS; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • CANCER RES TREAT 2025 10.4143/crt.2023.1285 Endoxifen Concentration Is Associated with Recurrence-Free Survival in Hormone-Sensitive Breast Cancer Patients Lee, B; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Lee, JE; Lee, SY
    View PubMed
  • INT J CLIN PRACT 2024 10.1155/2024/1805803 Outcomes of Tamoxifen Treatment Alone in Patients With Ductal Carcinoma In Situ or Atypical Ductal Hyperplasia Who Refused Surgery Kwak, Y; Ryu, JM; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • JAMA NETW OPEN 2024 10.1001/jamanetworkopen.2024.42663 Age and Late Recurrence in Young Patients With ER-Positive, ERBB2-Negative Breast Cancer Shin, DS; Lee, JH; Kang, E; Noh, D; Cheun, JH; Lee, JH; Son, Y; Bae, SJ; Kim, SW; Lee, JE; Yu, JH; Chae, BJ; Kwon, S; Lee, HB; Ahn, SG; Ryu, JM
    View PubMed
  • EJSO-EUR J SURG ONC 2024 10.1016/j.ejso.2024.108644 Evaluating the feasibility of repeat sentinel lymph node biopsy in ipsilateral breast tumor recurrence: Technical considerations and oncologic outcomes Park, WK; Kim, HJ; Ryu, JM; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • CANCER-AM CANCER SOC 2024 10.1002/cncr.35567 Nonsentinel lymph node metastases in cases of micrometastasis detected by sentinel lymph node biopsy after neoadjuvant chemotherapy Shin, DS; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • J BREAST CANCER 2024 10.4048/jbc.2023.0234 Intensive Surveillance for Women With Breast Cancer: A Multicenter Retrospective Study in Korea Park, S; Moon, HG; Lee, JW; Kim, KS; Kim, Z; Jung, SY; Lee, JHY; Lee, SK; Chae, BJ; Jung, SU; Chun, JW; Cheun, JH; Youn, HJ
    View PubMed
  • CANCERS 2024 10.3390/cancers16142566 The Prognostic Impact of HER2-Low and Menopausal Status in Triple-Negative Breast Cancer Park, WK; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Lee, SK; Ryu, JM; Chae, B
    View PubMed
  • SCI REP-UK 2024 10.1038/s41598-024-61640-z Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification Lee, M; Yoo, TK; Chae, BJ; Lee, A; Cha, YJ; Lee, J; Ahn, SG; Kang, J
    View PubMed
  • CANCERS 2024 10.3390/cancers16101865 The Effects of National Insurance Coverage Expansion and Genetic Counseling's Role on BRCA1/2 Mutation Tests in Breast Cancer Patients Jang, SY; Kwak, Y; Choi, JY; Shin, DS; Lee, H; Kim, M; Jung, BY; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • NPJ PRECIS ONCOL 2024 10.1038/s41698-024-00559-0 Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutations Park, WK; Chung, SY; Jung, YJ; Ha, C; Kim, JW; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, JE; Kim, SW; Ryu, JM
    View PubMed
  • BMC WOMENS HEALTH 2024 10.1186/s12905-024-02973-9 Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients Kim, EY; Lee, KH; Yun, JS; Park, YL; Park, CH; Jang, SY; Ryu, JM; Lee, SK; Chae, BJ; Lee, JE; Kim, SW; Nam, SJ; Yu, JH
    View PubMed
  • J BREAST CANCER 2024 10.4048/jbc.2023.0196 Oncologic Outcomes of Immediate Breast Reconstruction in the Setting of Neoadjuvant Chemotherapy: A Long-term Follow-up Study of a Matched Cohort Shin, DS; Bang, YJ; Choi, JY; Jang, SY; Lee, H; Kwak, Y; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Jeon, BJ; Pyon, JK; Mun, GH; Lee, KT; Ryu, JM
    View PubMed
  • BREAST CANCER-TOKYO 2024 10.1007/s12282-024-01547-9 Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants Kim, N; Cho, WK; Park, W; Lee, JE; Nam, SJ; Kim, SW; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Ko, ES; Kim, H
    View PubMed
  • BREAST 2023 10.1016/j.breast.2023.103594 Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer Kim, N; Kim, JY; Park, W; Cho, WK; Kim, TG; Im, YH; Ahn, JS; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Park, YH; Kim, H
    View PubMed
  • CANCERS 2023 10.3390/cancers15225473 The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis Kim, K; Park, W; Kim, H; Cho, WK; Kim, N; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM
    View PubMed
  • CANCERS 2023 10.3390/cancers15225361 The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer Park, WK; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Ryu, JM; Chae, BJ
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1230310 Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study Choi, JY; Woen, D; Jang, SY; Lee, H; Shin, DS; Kwak, Y; Lee, H; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • WORLD J CLIN CASES 2023 10.12998/wjcc.v11.i27.6398 Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy Choi, HJ; Lee, JH; Jung, CS; Ryu, JM; Chae, BJ; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE; Jung, YJ; Kim, HY
    View PubMed
  • JMIR PUBLIC HLTH SUR 2023 10.2196/45212 Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis Kang, D; Kim, H; Cho, J; Kim, Z; Chung, M; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Lee, SK
    View PubMed
  • CANCERS 2023 10.3390/cancers15133435 Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study Kwak, Y; Jang, SY; Choi, JY; Lee, H; Shin, DS; Park, YH; Kim, JY; Ahn, JS; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • EXP MOL MED 2023 10.1038/s12276-023-01030-z Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer Kim, JY; Park, S; Cho, EY; Lee, JE; Jung, HH; Chae, BJ; Kim, SW; Nam, SJ; Cho, SY; Park, YH; Ahn, JS; Lee, S; Im, YH
    View PubMed
  • ANN SURG TREAT RES 2023 10.4174/astr.2023.105.1.10 Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study Kim, YJ; Kim, HJ; Chung, SY; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • J BREAST CANCER 2023 10.4048/jbc.2023.26.e11 Impact of Adjuvant Hormone Therapy on Sleep, Physical Activity, and Quality of Life in Premenopausal Breast Cancer: 12-Month Observational Study Yeo, SM; Lim, JY; Kim, SW; Chae, BJ; Yu, JH; Ryu, JM; Hwang, JH
    View PubMed
  • CANCERS 2023 10.3390/cancers15051556 Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis Lee, JH; Ryu, JM; Lee, SK; Chae, BJ; Lee, JE; Kim, SW; Nam, SJ; Yu, J
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1039670 The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial Bang, YJ; Choi, HJ; Kim, I; Lee, MH; Lee, SY; Shin, HJ; Nam, SJ; Lee, JE; Chae, BJ; Lee, SK; Ryu, JM; Kim, SW
    View PubMed
  • HEALTH INFORM J 2023 10.1177/14604582231156476 Feasibility and usability of a personalized mHealth app for self-management in the first year following breast cancer surgery Lim, JY; Kim, Y; Yeo, SM; Chae, BJ; Yu, JH; Hwang, JH
    View PubMed
  • BREAST 2022 10.1016/j.breast.2022.09.004 Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/ nipple-sparing mastectomy Kim, N; Park, W; Cho, WK; Kim, HY; Choi, DH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Mun, GH; Pyon, JK; Jeon, BJ
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e49 Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay Lee, JH; Ryu, JM; Ahn, JH; Cho, SY; Lee, SK; Yu, J; Chae, BJ; Nam, SJ; Han, J; Lee, JE; Kim, SW
    View PubMed
  • J CLIN MED 2022 10.3390/jcm11216564 Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy? Choi, HJ; Ryu, JM; Lee, JH; Bang, Y; Oh, J; Chae, BJ; Nam, SJ; Kim, SW; Lee, JE; Lee, SK; Yu, J
    View PubMed
  • CANCERS 2022 10.3390/cancers14194839 Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort Jo, H; Park, S; Kim, HR; Kim, H; Hong, J; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Oh, SY; Choi, SJ; Kim, JY; Ahn, JS; Im, YH; Nam, EM; Nam, SJ; Park, YH
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e33 Multicentric Breast Cancer of the Axillary and Pectoral Breasts: A Case Report and Literature Review Kim, H; Ko, EY; Han, BK; Kim, JY; Chae, BJ; Lee, H
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.901 Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/ Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience Kim, JY; Nam, SJ; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Ahn, JS; Im, YH; Kim, SW; Park, YH
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e36 Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma Lee, JH; Lee, H; Bang, YJ; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.791 Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients Bang, YJ; Kwon, WK; Nam, SJ; Kim, SW; Chae, BJ; Lee, SK; Ryu, JM; Kim, JW; Yu, J; Lee, JE
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.784 Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivors Shim, S; Kang, D; Kim, N; Han, G; Lim, J; Kim, H; Park, J; Lee, M; Lee, JE; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Nam, SJ; Lee, SK; Cho, J
    View PubMed
  • BREAST CANCER RES TR 2022 10.1007/s10549-021-06500-4 Surgical margin status and survival outcomes of breast cancer patients treated with breast-conserving surgery and whole-breast irradiation after neoadjuvant chemotherapy Cheun, JH; Lee, YJ; Lee, JH; Shin, Y; Chun, JW; Baek, SY; Kim, HK; Lee, HB; Yu, J; Chae, BJ; Han, W; Lee, JE
    View PubMed
  • CURR ONCOL 2022 10.3390/curroncol29050267 Primary Angiosarcoma of the Breast: A Single-Center Retrospective Study in Korea Kim, YJ; Ryu, JM; Lee, SK; Chae, BJ; Kim, SW; Nam, SJ; Yu, JH; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2022 10.1007/s10549-021-06437-8 A triple-negative breast cancer surrogate subtype classification that correlates with gene expression subtypes Yoo, TK; Kang, J; Lee, A; Chae, BJ
    View PubMed
  • J BREAST CANCER 2021 10.4048/jbc.2021.24.e51 A Randomized Controlled Trial for Doing vs. Omitting Intraoperative Frozen Section Biopsy for Resection Margin Status in Selected Patients Undergoing Breast-Conserving Surgery (OFF-MAP Trial) Yoo, TK; Kang, YJ; Jeong, J; Song, JY; Kang, SH; Lee, HY; Kim, ET; Yi, O; Lee, HB; Choi, S; Park, HS; Gwak, G; Kim, JI; Kim, MK; Lee, J; Kang, HJ; Chae, BJ
    View PubMed
  • J CLIN MED 2021 10.3390/jcm10204754 Is Sentinel Lymph Node Biopsy for Breast Cancer with Cytology-Proven Axillary Metastasis Safe? A Prospective Single-Arm Study Choi, HJ; Ryu, JM; Chae, BJ; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW
    View PubMed
  • J BREAST CANCER 2021 10.4048/jbc.2021.24.e30 Effect of Poloxamer-Based Thermo- Sensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical Trial Choi, HJ; Ryu, JM; Chae, BJ; Kim, EK; Min, JW; Shin, HJ; Nam, SJ; Yu, J; Lee, JE; Lee, SK; Kim, SW
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-94195-4 Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients Woo, J; Gwak, G; Park, I; Bae, BN; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • BMC CANCER 2021 10.1186/s12885-021-08494-0 Cardiovascular events and mortality in a population-based cohort initially diagnosed with ductal carcinoma in situ Yoo1, TK; Park, SH; Han, KD; Chae, BJ
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.691277 Validation of the Clinical Treatment Score Post-Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea Lee1, JH; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • BMC CANCER 2021 10.1186/s12885-021-08355-w Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: a large, multicenter, observational study Woo1, J; Oh, SJ; Song, JY; Chae, BJ; Choi, JE; Lee, J; Park, HK; Lim, W
    View PubMed
  • CANCERS 2021 10.3390/cancers13051177 Changes in Metabolic Syndrome Status and Breast Cancer Risk: A Nationwide Cohort Study Choi1, IY; Chun, S; Shin, DW; Han, K; Jeon, KH; Yu, J; Chae, BJ; Suh, M; Park, YM
    View PubMed
  • J BREAST CANC 2021 10.4048/jbc.2021.24.e4 Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer Min1, SK; Lee, SK; Woo, J; Jung, SM; Ryu, JM; Yu, J; Lee, JE; Kim, SW; Chae, BJ; Nam, SJ
    View PubMed
  • EJSO-EUR J SURG ONC 2021 10.1016/j.ejso.2020.08.023 Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer Woo1, J; Ryu, JM; Jung, SM; Choi, HJ; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • BMC CANCER 2021 10.1186/s12885-020-07729-w Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander? Jung1, SM; Jeon, BJ; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Pyon, JK; Mun, GH; Bang, SI; Lee, JE
    View PubMed
  • ANN SURG TREAT RES 2020 10.4174/astr.2020.99.5.251 Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer? Jung1, SM; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Kim, EJ; Lee, JE
    View PubMed
  • CANCER EPIDEM BIOMAR 2020 10.1158/1055-9965.EPI-20-0038 Hormone Replacement Therapy, Breast Cancer Risk Factors, and Breast Cancer Risk A Nationwide Population-Based Cohort Yoo1, TK; Han, KD; Kim, D; Ahn, J; Park, WC; Chae, BJ
    View PubMed
  • BREAST CANCER RES TR 2020 10.1007/s10549-020-05636-z Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis Yoo1, TK; Kang, BJ; Kim, SH; Song, BJ; Ahn, J; Park, WC; Chae, BJ
    View PubMed
  • CLIN BREAST CANCER 2020 10.1016/j.clbc.2019.11.011 A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ Yoo1, TK; Kim, SJ; Lee, J; Lee, SB; Lee, SJ; Park, HY; Park, HK; Chae, BJ; Eom, YH; Kim, HS; Song, BJ
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9041192 Aberrant Lymphatic Drainage in the Contralateral Axilla in Patients with Isolated Ipsilateral Breast Tumor Recurrence Ryu1, JM; Chae, BJ; Lee, JE; Yu, J; Nam, SJ; Kim, SW; Lee, SK
    View PubMed
  • BREAST CANCER RES TR 2020 10.1007/s10549-020-05550-4 The prognostic value of HER2 status and efficacy of anti-HER2 therapy in patients with HR-positive mucinous breast cancer: a nationwide study from the Korean Breast Cancer Society Kim1, HS; Yoo, TK; Park, WC; Chae, BJ
    View PubMed
  • JPN J CLIN ONCOL 2020 10.1093/jjco/hyz147 Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors Ryu1, JM; Nam, SJ; Kim, SW; Lee, JE; Chae, BJ; Lee, SK; Yu, J
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e48 Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm Alsharif1, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e46 Omission of Chemotherapy for the Treatment of Mucinous Breast Cancer: A Nationwide Study from the Korean Breast Cancer Society Kim1, HS; Lee, JU; Yoo, TK; Chae, BJ; Son, D; Kim, YJ; Park, WC
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e35 Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype(-) Breast Cancer Kim1, HS; Yoo, TK; Park, WC; Chae, BJ
    View PubMed
  • BMC CANCER 2019 10.1186/s12885-019-6064-8 Unmet needs and related factors of Korean breast cancer survivors: a multicenter, cross-sectional study Chae1, BJ; Lee, J; Lee, SK; Shin, HJ; Jung, SY; Lee, JW; Kim, Z; Lee, MH; Lee, J; Youn, HJ
    View PubMed